Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
akinetic mute
bradykinesia
cortical-basal ganglionic degeneration
degenerative diseases of CNS
dementia
dementia, frontotemporal
differential diagnosis
gaze palsy, vertical
imbalance, postural
L-dopa
MRI
MRI, abnormal
multiple system atrophy
neurologic signs
neuropathology
neuropathology, brain
ophthalmoplegia
ophthalmoplegia, total
Parkinson disease
Parkinson disease, akinetic form
Parkinson disease, atypical
Parkinson disease, diagnosis
Parkinson disease, heterogeneity of
Parkinson disease, L-dopa nonresponsive
Parkinsonism syndrome
prognosis
progressive supranuclear palsy
rapidly progressing neurologic illness
review article
rigidity, axial
sinemet
synucleinopathy
tau protein
tauopathy
treatment of neurologic disorder
Showing articles 900 to 950 of 1347 << Previous Next >>

Lisuride, A Dopamine Agonist in the Treatment of Early Parkinson's Disease
Neurol 39:336-339, Rinne,U.K., 1989

The Olfactory and Cognitive Deficits of Parkinson's Disease:Evidence for Independence
Ann Neurol 25:166-171, Doty,R.L.,et al, 1989

Special Report of Fetal Tissue Transplants
National Right to Life News, January 22, 16:1-18989., , 1989

Multicenter Study of Autologous Adrenal Medullary Transplantation to Corpus Striatum in Pts with Advanced Parkinson's Dis
NEJM 320:337-341, Goetz,C.G.,et al, 1989

Autopsy Findings in a Patient Who Had an Adrenal-To-Brain Transplant for Parkinson's Disease
Neurol 39:235-238, Peterson,D.I.,et al, 1989

MR Imaging of Parkinson Disease with Spin-Echo and Gradient-Echo Sequences
AJR 152:159-165, Braffman,B.H.,et al, 1989

A Double-Blind Crossover Comparison of Sinemet CR4 and Standard Sinemet 25/100 in Patients with Parkinson's Disease
JNNP 52:207-212, Cedarbaum,J.M.,et al, 1989

Efficacy of Sinemet CR4 in Subgroups of Patients with Parkinson's Disease
JNNP 52:83-88, Factor,S.A.,et al, 1989

Frozen Shoulder and Other Shoulder Disturbances in Parkinson's Disease
JNNP 52:63-66, Riley,D.,et al, 1989

Cyanide-Induced Parkinsonism:Clinical, MRI, and 6-Fluorodopa PET Studies
Neurol 39:142-144, Rosenberg,N.L.,et al, 1989

Bromocriptine in Parkinson's Disease:A Double-Blind Study Comparing"Low-Slow"and"High-Fast"in de Novo Patients
UK Bromocriptine Res Group, JNNP 52:77-821989., , 1989

Dose-Dependent Memory Impairment in Parkinson's Disease
Neurol 39:438-440, Huber,S.J.,et al, 1989

Controlled Release of Dopamine from a Polymeric Brain Implant:In Vivo Characterization
Ann Neurol 25:351-356, During,M.J.,et al, 1989

Current Theories on the Cause of Parkinson's Disease
JNNP Suppl (June) 52:13-17989., Langston,J.W., 1989

Acute Postoperative Confusion and Hallucinations in Parkinson Disease
Ann Int Med 111:218-222, Golden,W.E.,et al, 1989

Clozapine in the Treatment of Psychosis in Parkinson's Disease
Neurol 39:1219-1221, Friedman,J.H.&Lannon,M.C., 1989

Induction of Parkinsonism by Intraventricular Bethanechol in a Patient with Alzheimer's Disease
Neurol 39:1265, Fox,J.H.,et al, 1989

Parkinsonism and Amiodarone Therapy
Ann Neurol 25:630-632, Werner,E.G.&Olanow,C.W., 1989

Metoclopramide-Induced Movement Disorders
Arch Int Med 149:2486-2492, Miller,L.G.&Jankovic,J., 1989

Mild Parkinsonism in Persons Exposed to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)
Neurol 39:1483-1487, Tetrud,J.W.,et al, 1989

Sleep Abnormalities in Progressive Supranuclear Palsy
Ann Neurol 25:577-581, Aldrich,M.S.,et al, 1989

Autologous Adrenal Medullary Transplant in Progressive Supranuclear Palsy
Neurol 39:1066-1068, Koller,W.C.,et al, 1989

MR Imaging in Progressive Suupranuclear Palsy and Shy-Drager Syndrome
J Comput Assist Tomogr 13:555-560, Savoiardo,M.,et al, 1989

Diltiazem-Induced Parkinsonism
Am J Med 87:95-96, Dick,R.S.&Barold,S.S., 1989

Risk Factors for Recurrent Nonsyncopal Falls, A Prospective Study
JAMA 261:2663-2668, Nevitt,M.C.,et al, 1989

Pergolide and Selegiline for Parkinson's Disease
The Medical Letter, 31:81-841989., , 1989

Continuous Levodopa Infusions to Treat Complex Dystonia in Parkinson's Disease
Neurol 39:888-891, Sage,J.I.,et al, 1989

Dopa Responsive Dystonia:A Treatable Condition Misdiagnosed as Cerebral Palsy
BMJ 298:1019-1020, Boyd,K.&Patterson,V., 1989

Cognitive Impairments Associated with Early Parkinson's Disease
Neurol 39:557-561, Levin,B.E.,et al, 1989

Clinical and Pathological Aspects of Parkinsonism in Alzheimer's Disease, A Role for Extranigral Factors?
Arch Neurol 46:651-657, Morris,J.C.,et al, 1989

Neuropathological Distinction Between Parkinson's Dementia and Parkinson's Plus Alzheimer's Disease
Ann Neurol 26:309-320, delaMonte,S.M.,et al, 1989

Environmental Factors and Parkinson's Disease:A Case-Control Study in China
Neurol 39:660-664, Tanner,C.M.,et al, 1989

Long-Term Efficacy and Safety of Deprenyl (Selegiline) in Advanced Parkinson's Disease
Neurol 39:1109-1111, Golbe,L.I.,et al, 1989

The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's Disease
Science 245:519-522, Tetrud,J.W.&Langston,W., 1989

Agonist Substitution in Advanced Parkinson's Disease
Neurol 39:1121-1122, Goetz,C.G.,et al, 1989

Physiology & Pharmacology of Dopamine D2-Receptors:Their Implications in Dopamine-Substitute Therapy for Park
Neurol 39:1106-1108, Mercuri,N.B.,et al, 1989

Human Fetal Dopamine Neurons Grafted Into the Striatum in Two Patients with Severe Parkinson's 6-Mo Follow-up
Arch Neurol 46:615-631, Lindvall,O.,et al, 1989

The Ethical Use of Human Fetal Tissue in Medicine
NEJM 320:1093-1096, Greely,H.T.,et al, 1989

The Politics of Transplantation of Human Fetal Tissue
NEJM 320:1079-1082, Annas,G.J.&Elias,S., 1989

Postmortem Analysis of Adrenal-Medulla-to-Caudate Autograft in a Patient with Parkinson's Disease
Ann Neurol 25:607-614, Hurtig,H.,et al, 1989

Adrenal Medullary Transplantation to the Caudate Nucleus in Parkinson's Disease, Initial Results in 18 Patients
Arch Neurol 46:487-491, Allen,G.S.,et al, 1989

Adrenal Medullary Autografts in Patients with Parkinson's Disease
NEJM 321:324-327, Tanner,C.M.,et al, 1989

Clinical, Biochem, & Neuropath of Transplantation of Adrenal Medulla to Caudate Nucleus for Parkinson's
Neurol 39:1227-1234, Jankovic,J.,et al, 1989

Amount and Distribution of Dietary Protein Affects Clinical Response to Levodopa in Parkinson's Disease
Neurol 39:552-556, Carter,J.H., 1989

Influence of Fluctuations of Plasma Large Neutral Amino Acids with Normal Diets on the Clinical Response to Levodopa
JNNP 52:481-487, Nutt,J.G.,et al, 1989

The Effect of Dietary Protein on the Efficacy of L-Dopa:A Double-Blind Study
Neurol 39:549-552, Tsui,J.K.,et al, 1989

Accuracy of Self-Reported Disability in Patients with Parkinsonism
Arch Neurol 46:955-959, Brown,R.G.,et al, 1989

Psychiatric Aspects of Parkinson's Disease, Dementia, Depression, and Rarely Psychosis
BMJ 299:3-4, Baldwin,R.C.&Byrne,E.J., 1989

Effect of Age at Onset on Progression and Mortality in Parkinson's Disease
Neurol 39:1187-1190, Diamond,S.G.,et al, 1989

Diffuse Lewy Body Disease:Clinical Features in 15 Cases
JNNP 52:709-717, Byrne,E.J., 1989



Showing articles 900 to 950 of 1347 << Previous Next >>